Saltar al contenido
Merck

Identification of the components of bitespiramycin by liquid chromatography-mass spectrometry.

Journal of pharmaceutical and biomedical analysis (2012-04-10)
Ming-juan Wang, Jing Xue, Wen-bo Zou, Yan Wang, Chang-qin Hu, Jos Hoogmartens, Erwin Adams
RESUMEN

Reversed-phase liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) was used to characterize the components of bitespiramycin, a group of 4"-acylated spiramycins produced by bioengineered strains. In total 38 components were characterized in commercial samples, including 12 impurities that had never been reported before and 12 other that were partially characterized. The structures of these unknown compounds were deduced by comparison of their fragmentation patterns with those of known major components. Their ultraviolet spectra were used to confirm the presence of an α-, β-, γ-, δ-unsaturated butadiene in the macrocyclic lactone. Compared with the classical method, LC/ESI-MS/MS is particularly advantageous in terms of sensitivity and efficiency to characterize minor components at trace levels in multi-component antibiotics.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Spiramycin
Spiramycin, European Pharmacopoeia (EP) Reference Standard
Supelco
Spiramycin from Streptomyces sp., VETRANAL®, analytical standard, mixture of isomers